ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,451 | -41.5% | 24,967 | -63.0% | 0.00% | – |
Q3 2022 | $64,000 | -36.6% | 67,564 | -19.5% | 0.00% | -100.0% |
Q2 2022 | $101,000 | +98.0% | 83,886 | +254.5% | 0.00% | 0.0% |
Q3 2021 | $51,000 | -58.9% | 23,662 | +106.8% | 0.00% | -50.0% |
Q4 2020 | $124,000 | -61.4% | 11,441 | -63.3% | 0.00% | -60.0% |
Q3 2020 | $321,000 | – | 31,151 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |